CAS 199657-29-9

Carbamic acid, N-[4-[(hydroxyamino)carbonyl]phenyl]-, [6-[(diethylamino)methyl]-2-naphthalenyl]methyl ester, hydrochloride (1:1)

CAS : 199657-29-9

Formule : C₂₄H₂₈ClN₃O₄

Degré de pureté : %

Masse moléculaire : 457.9498

Ref: IN-DA002C8S

Givinostat hydrochloride

CAS : 199657-29-9

Givinostat hydrochloride

Degré de pureté : ≥98%

Masse moléculaire : 457.95g/mol

Ref: 54-BUP09487

Givinostat hydrochloride

CAS : 199657-29-9

Givinostat HCl (ITF2357 HCl) inhibits HDAC1/3 (IC50: 198/157 nM) with anti-inflammatory, anti-angiogenic, and antineoplastic properties.

Formule : C₂₄H₂₈ClN₃O₄

Degré de pureté : 99.39%

Couleur et forme : Solid

Masse moléculaire : 457.95

Ref: TM-T6279L

Givinostat hydrochloride

CAS : 199657-29-9

Givinostat hydrochloride is a research chemical that has shown potential in various fields. It is a molybdenum-based compound that has been studied for its effects on dopamine release and hydrogen evolution. Givinostat hydrochloride has also been investigated as an osteoclast inhibitor, which may be beneficial in the treatment of bone-related disorders such as osteoporosis. Additionally, it has shown promise as a retinoid and calpain inhibitor, suggesting its potential use in dermatological conditions and neurodegenerative diseases. The compound contains fluorine atoms, making it suitable for imaging studies using fluorine MRI techniques. Givinostat hydrochloride has been tested on MDA-MB-231 cells and has shown inhibitory effects on their growth, indicating its potential as an anticancer agent.

Formule : C₂₄H₂₇N₃O₄·HCl

Degré de pureté : Min. 95%

Masse moléculaire : 457.95 g/mol

Ref: 3D-ZHA65729